Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01202656 · ClinicalTrials.gov registry record · Phase 1
Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization)
A Phase 1 study, sponsored by Center for Human Reproduction.
- Completed
- Registry status
- Phase 1
- Development phase
- 129
- Enrollment target
NCT01202656 is a Phase 1 study that has completed, run by Center for Human Reproduction. The registered enrollment target is 129 participants.
The verdict
NCT01202656, a Phase 1 study, has completed, sponsored by Center for Human Reproduction.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 129 participants
- Enrollment target
Study Summary
This a trial designed to test whether granulocyte colony stimulating factor (G-CSF, Neupogen) can increase the rate of embryo implantation following IVF and embryo transfer. Preliminary data at the Center for Human Reproduction(CHR) and elsewhere suggest that intrauterine infusion of G-CSF can improve endometrial development and can increase implantation rates of embryos.
Interventions
- DRUG G-CSF
- DRUG Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01202656
The ClinicalTrials.gov registry entry for NCT01202656 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for Human Reproduction, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which G-CSF is the first listed.
NCT01202656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01202656 about?
NCT01202656 is a clinical study titled "Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization)". This a trial designed to test whether granulocyte colony stimulating factor (G-CSF, Neupogen) can increase the rate of embryo implantation following IVF and embryo transfer. Preliminary data at the Center for Human Reproduction(CHR) and elsewhere suggest that intrauterine infusion of G-CSF can impro...
What is the current status of trial NCT01202656?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 129 participants. The study started on 2010-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01202656?
The interventions under investigation include: G-CSF (DRUG), Saline (DRUG).
Who is sponsoring clinical trial NCT01202656?
This trial is sponsored by Center for Human Reproduction, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.